Back to top

Image: Bigstock

Seres Therapeutics (MCRB) Catches Eye: Stock Gains 9.2%

Read MoreHide Full Article

Seres Therapeutics, Inc. (MCRB - Free Report) was a big mover last session, as the company saw its shares rise a little above 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company as the stock is now trading above the volatile price range of $10.73 to $12.46 in the past one-month time frame.

The company has seen one positive estimate revision in the past 30 days. Also, its Zacks Consensus Estimate moved higher over the same timeframe. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
 
Seres Therapeutics currently holds a Zacks Rank #2 (Buy), while its Earnings ESP is negative.

Seres Therapeutics, Inc. Price

 

Another top-ranked stock in the Medical - Biomedical and Genetics industry is Vertex Pharmaceuticals Incorporated (VRTX - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is MCRB going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Vertex Pharmaceuticals Incorporated (VRTX) - free report >>

Seres Therapeutics, Inc. (MCRB) - free report >>

Published in